Obese

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Rivus Pharmaceuticals
Rivus PharmaceuticalsVA - Charlottesville
1 program
1
HU6 TabletPhase 11 trial
Active Trials
NCT05433506CompletedEst. Mar 2023
Pfizer
PfizerNEW YORK, NY
1 program
Growth hormone treatmentN/A1 trial
Active Trials
NCT01421589Completed15Est. Mar 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Rivus PharmaceuticalsHU6 Tablet
PfizerGrowth hormone treatment

Clinical Trials (2)

Total enrollment: 15 patients across 2 trials

NCT05433506Rivus PharmaceuticalsHU6 Tablet

Safety and Pharmacokinetics of HU6

Start: Sep 2022Est. completion: Mar 2023
Phase 1Completed
NCT01421589PfizerGrowth hormone treatment

Growth Hormone Treatment on Phosphocreatine Recovery in Obesity

Start: Sep 2011Est. completion: Mar 201315 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space